Flow-injection on-line oxidizing fluorimetry and solid phase extraction for determination of THIORIDAZINE HYDROCHLORIDE (cas 1257-76-7) in human plasma

Add time:08/09/2019    Source:sciencedirect.com

A simple, sensitive and specific fluorimetric method has been developed for the determination of THIORIDAZINE HYDROCHLORIDE (cas 1257-76-7) in human plasma involving solid phase extraction (SPE). In a flow-injection system, thioridazine hydrochloride is on-line oxidized into a strongly fluorescent compound with a lead dioxide solid-phase reactor and the fluorescence intensity is measured with a fluorescence detector (λex = 349 nm, λem = 429 nm). A comparison of plasma sample pretreatment between SPE procedure and precipitation method was made and the results showed that SPE procedure was better than precipitation method. Under the optimum conditions, the fluorescence intensity is proportional to the concentration of thioridazine hydrochloride in the range from 0.015 to 2.000 μg mL−1. The detection limit is 5.5 ng mL−1 of thioridazine hydrochloride and the relative standard deviation is 1.06%. This method has been applied to determination of thioridazine hydrochloride in real patients plasma samples with the results compared with those obtained by HPLC method.

We also recommend Trading Suppliers and Manufacturers of THIORIDAZINE HYDROCHLORIDE (cas 1257-76-7). Pls Click Website Link as below: cas 1257-76-7 suppliers

Prev:Applications of quantitative structure-activity relationships to drug design of piperazine derivatives
Next:Chemiluminescence determination of THIORIDAZINE HYDROCHLORIDE (cas 1257-76-7) by flow-injection analysis)